CONTEXT: Sudden infant death syndrome (SIDS) is a leading cause of postneonatal infant mortality. Our previous meta-analyses showed that any breastfeeding is protective against SIDS with exclusive breastfeeding conferring a stronger effect.The duration of breastfeeding required to confer a protective effect is unknown.
OBJECTIVE: To assess the associations between breastfeeding duration and SIDS.
DATA SOURCES: Individual-level data from 8 case-control studies.
STUDY SELECTION: Case-control SIDS studies with breastfeeding data.
DATA EXTRACTION: Breastfeeding variables, demographic factors, and other potential confounders were identified. Individual-study and pooled analyses were performed.
RESULTS: A total of 2267 SIDS cases and 6837 control infants were included. In multivariable pooled analysis, breastfeeding for <2 months was not protective (adjusted odds ratio [aOR]: 0.91, 95% confidence interval [CI]: 0.68–1.22). Any breastfeeding ≥2 months was protective, with greater protection seen with increased duration (2–4 months: aOR: 0.60, 95% CI: 0.44–0.82; 4–6 months: aOR: 0.40, 95% CI: 0.26–0.63; and >6 months: aOR: 0.36, 95% CI: 0.22–0.61). Although exclusive breastfeeding for <2 months was not protective (aOR: 0.82, 95% CI: 0.59–1.14), longer periods were protective (2–4 months: aOR: 0.61, 95% CI: 0.42–0.87; 4–6 months: aOR: 0.46, 95% CI: 0.29–0.74).
LIMITATIONS: The variables collected in each study varied slightly, limiting our ability to include all studies in the analysis and control for all confounders.
CONCLUSIONS: Breastfeeding duration of at least 2 months was associated with half the risk of SIDS. Breastfeeding does not need to be exclusive to confer this protection.
- aOR —
- adjusted odds ratio
- CESDI —
- Confifential Inquiry into Stillbirth and Deaths in Infancy
- CI —
- confidence interval
- CIMS —
- Chicago Infant Mortality Study
- ECAS —
- European Concerted Action on SIDS
- GeSID —
- German SIDS Study
- NZCDS —
- New Zealand Cot Death Study
- OR —
- odds ratio
- SES —
- socioeconomic status
- SIDS —
- sudden infant death syndrome
- SWISS —
- South-West England Infant Sleep Study
Breastfeeding has been shown in several studies to be associated with a decreased risk of sudden infant death syndrome (SIDS).1–3 In a previous meta-analysis, we have shown that breastfeeding is protective against SIDS (adjusted odds ratio [aOR]: 0.55, 95% confidence interval [CI]: 0.44–0.69 for any breastfeeding) and that this protective effect is stronger with exclusive breastfeeding (odds ratio [OR]: 0.27, 95% CI: 0.24–0.31).3
However, it has been difficult to determine what duration of breastfeeding is required to confer a protective effect against SIDS. This may partly be because the incidence of breastfeeding across countries and different cultures varies and because the authors of different studies investigating the association with SIDS use different definitions for any breastfeeding, exclusive breastfeeding, and the duration of either practice. Meta-analyses of breastfeeding duration at the study level are difficult to undertake, and, so far, the effect size and the duration of breastfeeding required to confer this protective effect have not been quantified.
We therefore aimed to use individual-level data from international studies and, with cooperation of the individual authors, to assess the associations between duration of any breastfeeding versus exclusive breastfeeding and SIDS.
We used the same review protocol as that in our previously reported meta-analysis.3 We searched the Ovid Medline database (January 1966 through December 2009) to collect data on breastfeeding and its association with SIDS. The search strategy included published articles limited to humans with the medical subject headings terms “sudden infant death” and “breast feeding” and with the key words “sudden infant death syndrome,” “SIDS,” “cot death,” and “breastfeeding.” Of the 18 studies included in the meta-analysis, individual level data were provided from 8 large case-control studies of SIDS deaths, which comprise all of the published case-control studies with individual-level data about breastfeeding status. In all studies, there were strict definitions and protocols for determining SIDS cases. The cause of death had to be ascertained by local medical examiners or pediatric or forensic pathologists. No studies without individual-level data were included. All data were obtained via direct contact with the original investigators for each case-control study. Data were checked by the original investigators for completeness and consistency before being released for this analysis. The studies included are detailed below.
The New Zealand Cot Death Study
The New Zealand Cot Death Study (NZCDS) was a national case-control study of all SIDS deaths that took place from November 1987 through October 1990. The authors of the study successfully recruited and obtained data from 393 case patients and 1592 controls, who were randomly selected from all birth cohorts, but with an age distribution to match the age of patients from cases from 1979 to 1984.4 Data were obtained by an interviewer-administered questionnaire and from hospital obstetric records, which included data about the type of feeding at the time of hospital discharge. Parents were asked whether the infant received any breast milk at any stage of life, in the first 4 weeks, and in the last 2 days. In addition, parents of infants who received any breast milk were asked at what stage breastfeeding stopped (age in weeks). Coding was available for never started and still breastfeeding.
The Chicago Infant Mortality Study
The authors of the Chicago Infant Mortality Study (CIMS) studied all SIDS deaths in Chicago, Illinois, between November 1993 and April 1996, and they included 260 case patients and 260 controls, who were matched by maternal ethnicity, age at death, and birth weight.5 Data on breastfeeding were collected by a standardized interviewer-administered questionnaire. Parents were asked if the child had ever been breastfed, if the child was still being breastfed, and how old the child was when breastfeeding stopped. In addition, data on other methods of feeding and when they were started were collected so that duration of exclusive breastfeeding could be calculated.
The German SIDS Study
The German SIDS Study (GeSID) was conducted in 11 of 18 states in the former Federal Republic of Germany between November 1998 and October 2001. The study included 333 SIDS case patients and 998 controls, who were matched by geographic region, age, sex, and reference sleep (ie, time of sleep was matched to the time of death for the respective case).6 Data on breastfeeding were collected by a standardized, interviewer-administered questionnaire. Questions were asked about breastfeeding at 2 weeks of age and at each month of age through 12 months (when applicable) and about whether this breastfeeding was exclusive.
The Scottish Cot Death Trust Study
The Scottish Cot Death Trust study took place between January 1996 and May 2000. Data were collected on 131 SIDS case patients and 278 control infants, who were matched by age, season, and obstetric unit.7 Data on breastfeeding were collected by a standardized, interviewer-administered questionnaire. Questions were asked about which types of feeding the infant had and, if not breastfed currently, whether they had ever breastfed and when they stopped.
European Concerted Action on SIDS
The European Concerted Action on SIDS (ECAS) comprised case-control studies in 20 regions in Europe between September 1992 and April 1996.8 Data for the current analyses were restricted to those centers for which we had not obtained data from elsewhere (Sweden, Norway, Denmark, Netherlands, Austria, Hungary, Ukraine, Spain, Italy, Russia, Slovenia, France, Belgium, Poland, and the United Kingdom [Cambridge]). Data were collected for 382 SIDS case patients and 1159 controls. Data on breastfeeding exclusivity and duration were collected by interviewer-administered questionnaires. Questions were asked about how the infant was being fed at the time of death or interview.
Irish Study of Infant Death
The Irish study was part of an ongoing case-control study of infant death in the Republic of Ireland that began collecting data in 1994 and continued until 2010.9,10 Controls were matched by date of birth and geographical location. The data included in this analysis comprise 363 case patients and 1163 controls for the period from 1994 to 2003. Data on breastfeeding exclusivity and duration were collected during standardized home interviews.
Confidential Inquiry Into Stillbirth and Deaths in Infancy
The Confidential Inquiry Into Stillbirth and Deaths in Infancy (CESDI) included 5 regions of England between 1993 and 1996.11 Data were collected for 325 SIDS case patients and 1300 controls, who were matched by age and health visitor. Data were collected for duration of breastfeeding; however, no information on the duration of exclusive breastfeeding was collected.
South-West England Infant Sleep Study
The South-West England Infant Sleep Study (SWISS) included 2 regions in the South-West of England between 2003 and 2006.12 Data were collected for 80 SIDS case patients and 87 controls. Data were collected for the duration of breastfeeding; however, no information on the duration of exclusive breastfeeding was collected.
Definitions of Breastfeeding Variables
Duration of any breastfeeding was defined as the length of time that the infant received any human milk, through breastfeeding or expressed breast milk, either exclusively or in combination with other foods (including infant formula). We defined the duration of any breastfeeding as a continuous variable; we created a categorical variable for the duration of any breastfeeding (0–2, 2–4, 4–6, and >6 months).
Duration of exclusive breastfeeding was defined as the length of time that the infant received only human milk, either through breastfeeding or expressed breast milk.13 We defined the duration of exclusive breastfeeding as a continuous variable; we created a categorical variable for the duration of exclusive breastfeeding (0–2, 2–4, and >4 months). A variable for >6 months was not created because of the small numbers in this group in most of the studies.
Analysis was performed for each study individually, and then data were combined for a pooled analysis. A pooled univariable analysis, using all 8 studies, was conducted, controlling for study. A multivariable model was then fitted by using 3 of the studies (the NZCDS, CIMS, and GeSID) for which all 19 potential confounders were available (model 1). These confounders had initially been assessed as being available and consistent across these 3 studies at the inception of each study and have been identified as risk or protective factors for SIDS: sleep position at last sleep (supine, side, prone), maternal smoking during pregnancy (yes/no), bed-sharing in the last sleep (infant sleeping with another person on the same surface) (yes/no), room-sharing in the last sleep (infant sleeping in the same room as an adult caregiver but on a separate surface) (yes/no), use of a dummy or pacifier in the last sleep (yes/no), maternal age, prenatal care received (yes/no), marital status (married/not married), parity (primiparous/multiparous), maternal education (university graduate or not), socioeconomic status (SES) (low, middle, high), infant age (<13, 13–19, 20–26, and >26 weeks), infant sex, admission to a special care infant unit (yes/no), season at death, birth weight (<2500 g, 2500–2999 g, 3000–3499 g, and ≥3500 g), gestational age at birth (28–33, 34–37, and 38+ weeks), multiple pregnancy (yes/no), and cesarean delivery (yes/no). Additional models were then fitted to include the other 5 studies, at the expense of reducing the number of confounders but increasing the sample size. These sequential models did not include the following confounders: cesarean delivery (the CESDI and SWISS included in model, model 2), SES and season (the Irish and ECAS studies included, model 3), and, finally, antenatal care and maternal education level (the Scottish study included, model 4).
All analyses were conducted in SAS version 9.4 (SAS Institute, Cary, NC). ORs were estimated by using the proc logistic procedure, with a strata statement for study in pooled analyses. Survival curves were produced for duration of any breastfeeding for control groups by using proc lifetest, with data censored if breastfeeding was still taking place. Statistical significance was defined at the 5% level.
This study was approved by the institutional review board at the University of Virginia. In addition, the individual studies were approved by the institutional ethical review boards and/or ethics committees according to the laws and standards of each country.
There are 8 SIDS case-control studies with individual-level data; all were included (see Supplemental Fig 2 flow diagram). A total of 2267 SIDS case patients and 6837 control infants were included in this analysis. There was great variability in the rates of any breastfeeding and exclusive breastfeeding in the studies (log rank: 1659.6, P < .0001). This is illustrated in Fig 1, which shows survival curves for any breastfeeding for controls from each of the studies. Breastfeeding rates were highest in New Zealand and lowest in the United States, with the European countries having intermediate rates. At 6 months, the rate of any breastfeeding ranged from over 50% in the NZCDS and ECAS to <10% in several of the studies.
The univariable effects of any breastfeeding stratified by study and the pooled analyses are shown in Table 1. The analysis categorizing duration of any breastfeeding showed that those who breastfed for <2 months incurred a protective effect (OR: 0.61, 95% CI: 0.54–0.69) and that those breastfeeding for 2 to 4 months had a greater protective effect (OR: 0.26, 95% CI: 0.22–0.30). Breastfeeding duration beyond 4 months provided further small increases in protection (4–6 months: OR: 0.18, 95% CI: 0.14–0.23; 6+ months: OR: 0.13, 95% CI: 0.10–0.18). The multivariable pooled analysis for the 3 studies with all 19 confounders controlled for found ongoing protective effects of any breastfeeding beyond 2 months (2–4 months: aOR: 0.60, 95% CI: 0.44–0.82; 4–6 months: aOR: 0.40, 95% CI: 0.26–0.63; and 6+ months: aOR: 0.36, 95% CI: 0.22–0.61) (Table 2). However, breastfeeding for 0 to 2 months did not have a statistically significant protective effect (aOR: 0.91, 95% CI: 0.68–1.21). The removal of cesarean delivery from the model had little effect on the ORs; however, the removal of SES and season in model 3 saw the protective effects of any breastfeeding become stronger. The further removal of maternal education and antenatal care in model 4 had little additional influence on the aOR, but this result reached statistical significance (aOR: 0.83, 95% CI: 0.70–0.99).
The stratified and pooled analysis for the univariable effects of exclusive breastfeeding is shown in Table 1. The analysis categorizing the duration of exclusive breastfeeding showed that those who exclusively breastfed for <2 months incurred a protective effect (OR: 0.61 95% CI: 0.53–0.71) and that those breastfeeding 2 to 4 months had a greater protective effect (OR: 0.25, 95% CI: 0.20–0.30). Exclusive breastfeeding for >4 months provided a further increase in protection (OR: 0.16, 95% CI: 0.12–0.21). As in the multivariable analysis for any breastfeeding, which controlled for all potential confounders, those who breastfed exclusively for <2 months did not see any statistically significant protective effect (aOR: 0.82, 95% CI: 0.59–1.14), but those who breastfed for longer than 2 months incurred a protective effect (aOR: 0.61, 95% CI: 0.42–0.97) for 2 to 4 months, with increasing protection with longer duration (aOR: 0.46, 95% CI: 0.29–0.74) for those exclusively breastfeeding >4 months. Similarly, the removal of SES and season from the model made the effect sizes slightly stronger (Table 3).
We conducted a pooled analysis of individual-level data from 8 major international case-control studies with 2259 case patients and 6894 controls to assess the association between duration of any breastfeeding versus exclusive breastfeeding and SIDS. Although there was some protection seen with breastfeeding for <2 months in univariable analysis, after controlling for potential confounders, we found no statistically significant protection against SIDS until infants had breastfed for at least 2 months. After 2 months, the aOR for any breastfeeding was 0.60 (95% CI: 0.44–0.82), whereas the aOR for exclusive breastfeeding was 0.61 (95% CI: 0.42–0.87). It is thus important that public health messages about SIDS risk reduction emphasize that breastfeeding, if it is to be protective, must continue for at least 2 months. This analysis does not reveal any advantage to exclusive breastfeeding over partial breastfeeding, which may be reassuring to some parents who cannot or do not wish to exclusively breastfeed their infant.
It is yet unclear why breastfeeding offers protective effects against SIDS. The authors of physiologic, neuropathologic, and genetic studies point to dysfunctional arousal responses as a mechanism that creates an intrinsic vulnerability in the infant, which predisposes the infant to SIDS,14 and breastfed infants are more easily aroused from sleep than are formula-fed infants.15,16 There are also differences in maternal responses to an infant’s behavioral cues, depending on feeding mode, which may impact infant sleep and arousal patterns.17,18 Additionally, breastfeeding provides immune benefits and is associated with a lower incidence of viral infections, which are associated with an increased risk of SIDS.19–21 Breast milk contains substances that may contribute to myelin development; Kinney and co-authors found that infants who died of SIDS had delayed myelination of the brain compared with control infants.22 Breast milk also contains higher levels than formula of docosahexaenoic acid, which is an important structural and functional component of the developing infant brain. One study of autopsied brains of SIDS infants found that the frontal lobes of the breastfed infants had higher levels of docosahexaenoic acid than those of formula-fed infants; it is unknown if this difference exists in non-SIDS infants.23 Finally, it is possible that breastfeeding is a distal marker of or proxy for complex protective infant care practices that have not yet been measured, although we would expect that such a marker would be related to sociodemographic variables that have been controlled for in these analyses.
It is unclear why exclusive breastfeeding did not offer any additional protection against SIDS than any, that is, partial, breastfeeding. This is a common challenge in studies in which the differential effects of exclusive and partial breastfeeding have been examined, because of the differing definitions of breastfeeding and confounding factors.1,24 The analysis accounted for as many demographic and risk factor variables as were possible, but we acknowledge that the effects reported could be caused by residual confounding, although this would be unlikely. It was notable that the inclusion of studies that did not have data on SES increased the protective effect further from the null, thus seemingly showing the importance of SES as a confounder in relation to breastfeeding. Given that lower SES is a risk factor for SIDS, it is possible that the protective effect of SES may in part be explained by increased breastfeeding rates. However, model 3, which did not have data on SES, also did not have data on season. Although SES is associated with breastfeeding, it is unlikely that there is a relationship between season and breastfeeding; thus, we believe that these changes in estimates are likely to be associated with SES.
Other limitations of this study are related to issues with combining data in the individual case-control studies. These case-control studies were all conducted in a rigorous manner and are the basis for most of the current infant safe sleep guidelines in developed countries.25–27 However, as noted above, the variables collected in the course of each study varied slightly, limiting our ability to include all studies in the analysis and control for all confounders. However, the results of the univariable analysis using only the 3 countries included in the completely controlled multivariable model (model 1) did not differ greatly from the univariable analysis with all 8 studies, so it is unlikely that including the additional studies would have changed the results of the analysis in any meaningful way.
Given these findings, there should be ongoing concerted efforts to increase the rates of breastfeeding initiation and maintenance. Among the control infants in 5 of the 8 countries in this analysis, the proportion of infants who were breastfeeding was <50% at 2 months of age and <30% at 4 months of age. In more recent years, national breastfeeding rates have increased; 2007 Organisation for Economic Co-operation and Development data show that the proportions of infants who were ever breastfed in the countries included in our study were 42% in Ireland, 75% in the United States, 77% in the United Kingdom, 85% in New Zealand, and 89% in the European Union.28 The World Health Organization’s 2025 targets for breastfeeding are to have >50% of infants exclusively breastfeeding for at least 6 months.13 Further increases in breastfeeding rates will result in lower infant mortality as a whole24,29 and in decreases in SIDS rates,3 specifically.
Breastfeeding duration of a minimum of 2 months appears to be necessary to confer a significant protective effect against SIDS, with an almost halving of the risk. The protective benefits of breastfeeding increase as the duration increases. However, exclusive breastfeeding does not confer additional benefits over partial breastfeeding with regards to SIDS risk reduction. Therefore, mothers should be encouraged to breastfeed for at least 2 months (and preferably longer). Even if mothers are unable to exclusively breastfeed, they can feel reassured that any breastfeeding provides protection against SIDS for their infants. Further study is still needed to better understand the mechanisms by which breastfeeding offers protection.
We acknowledge Drs Robert Carpenter (deceased) and Mechtild Vennemann for their work in data collection and data analysis for this study.
- Accepted August 7, 2017.
- Address correspondence to John M.D. Thompson, PhD, Department of Paediatrics: Child and Youth Health, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. E-mail:
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: Funding for the New Zealand Cot Death Study was provided by the Health Research Council of New Zealand and the Hawkes Bay Medical Research Foundation. Funding for the Chicago Infant Mortality Study was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute on Deafness and Other Communication Disorders, the Centers for Disease Control and Prevention, and the Association of Teachers of Preventive Medicine. Funding for the German Sudden Infant Death Syndrome Study was provided by Germany’s Federal Ministry for Science and Education. Funding for The Scottish Cot Death Trust Study was provided by The Scottish Cot Death Trust. Funding for the European Concerted Action on Sudden Infant Death Syndrome was provided by the European Union and the Foundation for the Study of Infant Deaths (now called the Lullaby Trust). Funding for the Irish Study of Infant Death was provided by Ireland’s Department of Health and Children. Funding for the Confidential Enquiry into Stillbirth and Deaths in Infancy was provided by the National Advisory Body for the Confidential Enquiry into Stillbirths and Deaths in Infancy, the Foundation for the Study of Infant Deaths (now called the Lullaby Trust), and Babes in Arms. Funding for the South-West England Infant Sleep Study was provided by the Foundation for the Study of Infant Deaths (now called the Lullaby Trust), Babes in Arms, and The Charitable Trusts of University Hospitals Bristol.
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
- Hauck FR,
- Thompson JM,
- Tanabe KO,
- Moon RY,
- Vennemann MM
- Tappin D,
- Brooke H,
- Ecob R,
- Gibson A
- McGarvey C,
- McDonnell M,
- Chong A,
- O’Regan M,
- Matthews T
- Matthews T,
- McDonnell M,
- McGarvey C,
- Loftus G,
- O’Regan M
- Fleming PJ,
- Blair PS,
- Pollard K, et al; CESDI SUDI Research Team
- World Health Organization/UNICEF
- Horne RS,
- Parslow PM,
- Ferens D,
- Watts AM,
- Adamson TM
- Blair PS,
- Ball HL
- Kramer MS,
- Guo T,
- Platt RW, et al
- Moon RY; Task Force on Sudden Infant Death Syndrome
- Public Health Agency of Canada
- Blair P,
- Inch S
- OECD Social Policy Division
- Copyright © 2017 by the American Academy of Pediatrics